Treating Chronic Pouchitis With a Low FODMAP Diet

Status Withdrawn

Clinical Trial Summary

We aim to determine whether low FODMAP diet in patients with chronic pouchitis will improve symptoms and pouch inflammation.

Clinical Trial Description

Following recruitment for entry into the study, subjects be asked to complete symptom surveys and provide a fecal sample for calprotectin measurement. Shortly after their screening visit, patients will be randomized 1:1 to either the low FODMAP diet (experimental) or regular diet (control) group. Patients in the experimental group will schedule a telephone visit with a registered dietician. During this approximately hour-long session, patients in the low FODMAP cohort will be counseled regarding FODMAP containing foods. They will be asked to adhere to this diet over the next 6 weeks. At the end of the 6 week period, subjects will complete a 3-day food diary. Those in the regular diet group will be contacted by the dietician and given an educational handout at the beginning of the study period regarding best dietary practices. At the end of the 6 week study period, both groups will again be asked to complete another set of symptom surveys and provide a fecal sample for calprotectin measurement. ;

Study Design

Related Conditions & MeSH terms

Pouchitis

Clinical Trial Details

NCT number	NCT04640155
Study type	Interventional
Source	Northwestern University
Contact
Status	Withdrawn
Phase	N/A
Start date	October 27, 2020
Completion date	October 27, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04979832` - GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis Patients After Restorative IPAA Surgery	Phase 1/Phase 2
Terminated	`NCT00061282` - Clotrimazole Enemas for Pouchitis in Children and Adults	Phase 1/Phase 2
Not yet recruiting	`NCT05829109` - Fecal Microbiota Transplant for Patients With Chronic Pouchitis	Early Phase 1
Recruiting	`NCT03136419` - Microbiota and Immune microEnvironment in Pouchitis	N/A
Completed	`NCT02201186` - To Determine the Effect of Honey Enema in the Treatment of Patients With Acute Pouchitis	Phase 2
Completed	`NCT02790138` - A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis	Phase 4
Not yet recruiting	`NCT01202396` - The Interaction Between Intestinal Microbiota, Innate Defense and Epithelial Integrity in the Development of Pouchitis	N/A
Completed	`NCT02428361` - Fecal Microbiota Transplant (FMT) for Pouchitis	Early Phase 1
Completed	`NCT03538366` - Fecal Microbiota Transplantation for Chronic Pouchitis	N/A
Completed	`NCT04763564` - Efficacy of Liraglutide Therapy in Patients With IPAA	Phase 2
Terminated	`NCT00583531` - Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis	Phase 2
Recruiting	`NCT03524352` - the Prophylaxis of Recurrent Pouchitis After Fecal Microbiota Transplant in UC With Ileo-anal Anastomosis	Phase 3
Completed	`NCT04820413` - Faecal Microbiota Transplantation From Normal Pouch Function Donor in the Treatment of Chronic Pouchitis	N/A
Recruiting	`NCT04089345` - Stelara fOr ChRonic AntibioTic rEfractory pouchitiS	Phase 3
Not yet recruiting	`NCT03526796` - Hyperbaric Oxygen Therapy for Antibiotic Refractory Pouchitis	N/A
Terminated	`NCT02782325` - Safety and Efficacy of Fecal Microbiome Transplantation (FMT) in the Treatment of Antibiotic Dependent Pouchitis (ADP)	Phase 1/Phase 2
Completed	`NCT02828410` - Nutritional Impact of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With IPAA	N/A
Recruiting	`NCT05578313` - Inflammatory Bowel Diseases (IBD) Cannabis Registry
Not yet recruiting	`NCT06316999` - Intestinal Ultrasound for the Evaluation of Pouchitis and Other Outcomes After Ileal Pouch-Anal Anastomosis	N/A
Terminated	`NCT04100291` - Faecal Microbiota Transplantation in the Treatment of Chronic Pouchitis	N/A